Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR for Pediatric Bipolar Depression
NCT00181896Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupropion in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Primary endpoints: Reduction in depression symptoms at 8 weeks, Children's Depression Rating Scale at 8 weeks and 1 more. Started Jan 2005; status: terminated.
02
Drugs
bupropion
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00181896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181896.